296 related articles for article (PubMed ID: 21571797)
21. [Nuclear oncology with monoclonal antibodies and peptides].
Hosono M
Kaku Igaku; 1998 Oct; 35(8):681-7. PubMed ID: 9847509
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin receptor PET imaging with Gallium-68 labeled peptides.
Win Z; Al-Nahhas A; Rubello D; Gross MD
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):244-50. PubMed ID: 17464267
[TBL] [Abstract][Full Text] [Related]
23. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
Mariani G; Erba PA; Signore A
J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
[No Abstract] [Full Text] [Related]
24. Main challenges in radiation protection with emerging radionuclide therapies.
Cunha L; Baete K; Leijen C; Jamar F
Q J Nucl Med Mol Imaging; 2023 Mar; 67(1):14-28. PubMed ID: 36598760
[TBL] [Abstract][Full Text] [Related]
25. Radiolabeled Dendrimers for Nuclear Medicine Applications.
Zhao L; Zhu M; Li Y; Xing Y; Zhao J
Molecules; 2017 Aug; 22(9):. PubMed ID: 28841180
[TBL] [Abstract][Full Text] [Related]
26. Radiometallated peptides for molecular imaging and targeted therapy.
Correia JD; Paulo A; Raposinho PD; Santos I
Dalton Trans; 2011 Jun; 40(23):6144-67. PubMed ID: 21350775
[TBL] [Abstract][Full Text] [Related]
27. Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.
Prior JO; Gillessen S; Wirth M; Dale W; Aapro M; Oyen WJG
Eur J Cancer; 2017 May; 77():127-139. PubMed ID: 28391026
[TBL] [Abstract][Full Text] [Related]
28. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.
Hamoudeh M; Kamleh MA; Diab R; Fessi H
Adv Drug Deliv Rev; 2008 Sep; 60(12):1329-46. PubMed ID: 18562040
[TBL] [Abstract][Full Text] [Related]
29. Molecular targeting with radionuclides: state of the science.
Britz-Cunningham SH; Adelstein SJ
J Nucl Med; 2003 Dec; 44(12):1945-61. PubMed ID: 14660721
[TBL] [Abstract][Full Text] [Related]
30. Paving the way to personalized medicine: production of some promising theragnostic radionuclides at Brookhaven National Laboratory.
Srivastava SC
Semin Nucl Med; 2012 May; 42(3):151-63. PubMed ID: 22475424
[TBL] [Abstract][Full Text] [Related]
31. Radiopharmaceutical development of radiolabelled peptides.
Fani M; Maecke HR
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S11-30. PubMed ID: 22388624
[TBL] [Abstract][Full Text] [Related]
32. The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy.
Lehenberger S; Barkhausen C; Cohrs S; Fischer E; Grünberg J; Hohn A; Köster U; Schibli R; Türler A; Zhernosekov K
Nucl Med Biol; 2011 Aug; 38(6):917-24. PubMed ID: 21843788
[TBL] [Abstract][Full Text] [Related]
33. Letter from the Editors: planar imaging in the age of SPECT.
Freeman LM; Blaufox MD
Semin Nucl Med; 2012 Jan; 42(1):1-2. PubMed ID: 22117807
[No Abstract] [Full Text] [Related]
34. Receptors on tumors studied with radionuclide scintigraphy.
Larson S
J Nucl Med; 1991 Jun; 32(6):1189-91. PubMed ID: 1646303
[No Abstract] [Full Text] [Related]
35. Radionuclides and radiopharmaceuticals for single-photon emission tomography, positron emission tomography and radiotherapy in Russia.
Krasikova RN; Kodina GE
Eur J Nucl Med; 1999 Jul; 26(7):774-88. PubMed ID: 10398826
[TBL] [Abstract][Full Text] [Related]
36. Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors.
Eberle AN; Mild G; Froidevaux S
J Recept Signal Transduct Res; 2004; 24(4):319-455. PubMed ID: 15648449
[TBL] [Abstract][Full Text] [Related]
37. An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases.
Tornesello AL; Tornesello ML; Buonaguro FM
Mini Rev Med Chem; 2017; 17(9):758-770. PubMed ID: 28117023
[TBL] [Abstract][Full Text] [Related]
38. Veterinary Nuclear Medicine again--commentary and remarks on: Krzemiński M et al. Veterinary nuclear medicine--a review. NMR 2004; 7: 177-182.
Balogh L; Máthé D; Andócs G; Polyák A; Király R; Thuróczy J; Szilágyi J; Chaudhari P; Janoki GA
Nucl Med Rev Cent East Eur; 2005; 8(1):50-2. PubMed ID: 15977150
[No Abstract] [Full Text] [Related]
39. Radiolabelled regulatory peptides for imaging and therapy.
Breeman WA; Kwekkeboom DJ; de Blois E; de Jong M; Visser TJ; Krenning EP
Anticancer Agents Med Chem; 2007 May; 7(3):345-57. PubMed ID: 17504160
[TBL] [Abstract][Full Text] [Related]
40. Preclinical in vivo cancer, straightway to patients?
de Jong M; Mather S; Maina T
Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):145-152. PubMed ID: 28347131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
